QUIDELORTHO CORP
QDEL · NASDAQ
Updated at 2026-10-13 14:39:09
- Today's High
- $13.78
- Today’s Low
- $13.33
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $13.44
- Previous Close
- $13.25
- Volume
- 2.61M
- Market Cap
- $908.62M
- P/E Ratio
- --
- EPS
- $-15.40
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- MEDICAL DEVICES
- Headquarters
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, UNITED STATES, 92121
- Country
- US
- Listing Date
- 1991-02-01
- Fiscal Year End
- December
- Shares Outstanding
- 68.19M
- CIK
- 0001906324
- Website
- www.quidelortho.com
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.
Financial Metrics
Revenue
2026-06-30
$630.9M
2026-03-31
$619.8M
2025-12-31
$723.6M
2025-09-30
$699.9M
Operating Expenses
2026-06-30
$294.7M
2026-03-31
$291.2M
2025-12-31
$386.7M
2025-09-30
$1.04B
Net Income
2026-06-30
-$92.9M
2026-03-31
-$91.8M
2025-12-31
-$130.7M
2025-09-30
-$733M
Net Profit Margin
2026-06-30
-14.72%
2026-03-31
-14.81%
2025-12-31
-18.06%
2025-09-30
-104.72%
Earnings Per Share
2026-06-30
$0.13
2026-03-31
$-0.04
2025-12-31
$0.46
2025-09-30
$0.80
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$90.2M
2026-03-31
$81.4M
2025-12-31
$43.2M
2025-09-30
-$597M
Effective Tax Rate
2026-06-30
-14.4%
2026-03-31
-15.47%
2025-12-31
-16.28%
2025-09-30
3.15%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $630.9M | $619.8M | $723.6M | $699.9M |
| Operating Expenses | $294.7M | $291.2M | $386.7M | $1.04B |
| Net Income | -$92.9M | -$91.8M | -$130.7M | -$733M |
| Net Profit Margin | -14.72% | -14.81% | -18.06% | -104.72% |
| Earnings Per Share | $0.13 | $-0.04 | $0.46 | $0.80 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $90.2M | $81.4M | $43.2M | -$597M |
| Effective Tax Rate | -14.4% | -15.47% | -16.28% | 3.15% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.